These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 28929376

  • 1. Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice.
    Teng B, Labazi H, Sun C, Yang Y, Zeng X, Mustafa SJ, Zhou Z.
    Purinergic Signal; 2017 Dec; 13(4):591-600. PubMed ID: 28929376
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors.
    Zhou Z, Sun C, Tilley SL, Mustafa SJ.
    Vascul Pharmacol; 2015 Oct; 73():78-85. PubMed ID: 25921923
    [Abstract] [Full Text] [Related]

  • 3. Impaired Aortic Contractility to Uridine Adenosine Tetraphosphate in Angiotensin II-Induced Hypertensive Mice: Receptor Desensitization?
    Zhou Z, Yadav VR, Sun C, Teng B, Mustafa JS.
    Am J Hypertens; 2017 Mar 01; 30(3):304-312. PubMed ID: 28034895
    [Abstract] [Full Text] [Related]

  • 4. Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors.
    Zhou Z, Merkus D, Cheng C, Duckers HJ, Jan Danser AH, Duncker DJ.
    Pharmacol Res; 2013 Jan 01; 67(1):10-7. PubMed ID: 23063485
    [Abstract] [Full Text] [Related]

  • 5. Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation.
    Zhou Z, de Wijs-Meijler D, Lankhuizen I, Jankowski J, Jankowski V, Jan Danser AH, Duncker DJ, Merkus D.
    Pharmacol Res; 2013 Nov 01; 77():22-9. PubMed ID: 23994209
    [Abstract] [Full Text] [Related]

  • 6. Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement.
    Zhou Z, Sorop O, de Beer VJ, Heinonen I, Cheng C, Jan Danser AH, Duncker DJ, Merkus D.
    Purinergic Signal; 2017 Sep 01; 13(3):319-329. PubMed ID: 28540569
    [Abstract] [Full Text] [Related]

  • 7. Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.
    Zhou Z, Matsumoto T, Jankowski V, Pernow J, Mustafa SJ, Duncker DJ, Merkus D.
    Pharmacol Res; 2019 Mar 01; 141():32-45. PubMed ID: 30553823
    [Abstract] [Full Text] [Related]

  • 8. Activation of adenosine A2A but not A2B receptors is involved in uridine adenosine tetraphosphate-induced porcine coronary smooth muscle relaxation.
    Sun C, Jiao T, Merkus D, Duncker DJ, Mustafa SJ, Zhou Z.
    J Pharmacol Sci; 2019 Sep 01; 141(1):64-69. PubMed ID: 31640919
    [Abstract] [Full Text] [Related]

  • 9. Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids.
    Zhou Z, Lankhuizen IM, van Beusekom HM, Cheng C, Duncker DJ, Merkus D.
    Front Pharmacol; 2018 Sep 01; 9():255. PubMed ID: 29632487
    [Abstract] [Full Text] [Related]

  • 10. Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.
    Durnin L, Hwang SJ, Kurahashi M, Drumm BT, Ward SM, Sasse KC, Sanders KM, Mutafova-Yambolieva VN.
    Proc Natl Acad Sci U S A; 2014 Nov 04; 111(44):15821-6. PubMed ID: 25341729
    [Abstract] [Full Text] [Related]

  • 11. Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors.
    Zhou Z, Chrifi I, Xu Y, Pernow J, Duncker DJ, Merkus D, Cheng C.
    Am J Physiol Heart Circ Physiol; 2016 Jul 01; 311(1):H299-309. PubMed ID: 27233766
    [Abstract] [Full Text] [Related]

  • 12. Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells.
    Gui Y, He G, Walsh MP, Zheng XL.
    J Cardiovasc Pharmacol; 2011 Dec 01; 58(6):654-62. PubMed ID: 21885991
    [Abstract] [Full Text] [Related]

  • 13. Sex Difference in Coronary Endothelial Dysfunction in Apolipoprotein E Knockout Mouse: Role of NO and A2A Adenosine Receptor.
    Zhou X, Teng B, Mustafa SJ.
    Microcirculation; 2015 Oct 01; 22(7):518-27. PubMed ID: 26201383
    [Abstract] [Full Text] [Related]

  • 14. Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis.
    Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T.
    Pflugers Arch; 2014 Feb 01; 466(2):331-42. PubMed ID: 23900807
    [Abstract] [Full Text] [Related]

  • 15. A(2A) adenosine receptor-mediated increase in coronary flow in hyperlipidemic APOE-knockout mice.
    Teng B, Mustafa SJ.
    J Exp Pharmacol; 2011 Jul 01; 2011(3):59-68. PubMed ID: 21847356
    [Abstract] [Full Text] [Related]

  • 16. Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.
    Sanjani MS, Teng B, Krahn T, Tilley S, Ledent C, Mustafa SJ.
    Am J Physiol Heart Circ Physiol; 2011 Dec 01; 301(6):H2322-33. PubMed ID: 21949117
    [Abstract] [Full Text] [Related]

  • 17. A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts.
    Zhou X, Teng B, Tilley S, Mustafa SJ.
    Am J Physiol Heart Circ Physiol; 2013 Dec 01; 305(11):H1668-79. PubMed ID: 24043252
    [Abstract] [Full Text] [Related]

  • 18. Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis.
    Grönros J, Wikström J, Brandt-Eliasson U, Forsberg GB, Behrendt M, Hansson GI, Gan LM.
    Am J Physiol Heart Circ Physiol; 2008 Nov 01; 295(5):H2046-53. PubMed ID: 18790840
    [Abstract] [Full Text] [Related]

  • 19. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P, Bousette N, Al-Ramli W, You Z, Behm DJ, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Atherosclerosis; 2009 Jun 01; 204(2):395-404. PubMed ID: 19111831
    [Abstract] [Full Text] [Related]

  • 20. Physiopathological implications of P2X1 and P2X7 receptors in regulation of glomerular hemodynamics in angiotensin II-induced hypertension.
    Franco M, Bautista-Pérez R, Cano-Martínez A, Pacheco U, Santamaría J, Del Valle Mondragón L, Pérez-Méndez O, Navar LG.
    Am J Physiol Renal Physiol; 2017 Jul 01; 313(1):F9-F19. PubMed ID: 28404593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.